Biotech News Summary: Most advancing and declining

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

Biotech News Summary: Most advancing and declining stocks

Posted by on Jan 18, 2013

Biotech stocks were down on Thursday, led by Celsion Corporation (NASDAQ:CLSN) with a fall of 9.75% after Brean Capital downgraded the stock to sell from buy and reduced its price target from $7 to $1.

Theravance Inc (NASDAQ:THRX) tumbled 7.81% after pricing public offering convertible subordinated debt offering.

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) plunged 6.28% on pricing stock offering at $7.50 per share.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) extended fall after Portfolio Grader recommended selling the FOLD stock.

VIVUS, Inc. (NASDAQ:VVUS) lost 4.19% after Brean Capital downgraded the stock to sell from hold.
InterMune, Inc. (NASDAQ:ITMN) declined 3.66% on pricing public offering of debt and common stock at $9.90 per share. JMP Securities has recently raised the stock from a market perform rating to an outperform rating.

Hemispherx BioPharma, Inc (NYSEAMEX:HEB) fell 3.08% after Robbins Arroyo LLP and Levi & Korsinsky filed class action lawsuits against the company.

Galena Biopharma Inc (NASDAQ:GALE) faced fourth decline in a row.

Sarepta Therapeutics Inc (NASDAQ:SRPT) retreated 2.75% after Wedbush trimmed the price target from USD 70.00 to USD 60.00 on the stock, reaffirming an outperform rating.

Sequenom, Inc. (NASDAQ:SQNM) trended down after Portfolio Grader recommended selling the stock.

Dendreon Corporation (NASDAQ NDN) turned red while Nektar Therapeutics (NASDAQ:NKTR) extended fall, both ended 2.25% down on Thursday.

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) continued to fall after disclosing plans to offer 4.4 million shares.

Despite hitting new high yesterday, Celgene Corporation (NASDAQ:CELG) edged down followed by Amgen, Inc. (NASDAQ:AMGN), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Exelixis, Inc. (NASDAQ:EXEL).

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) traded below average-volume while CEL-SCI Corporation (NYSEAMEX:CVM) traded above average-volume.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was the most active stock in the industry but showed no change by the end of trade on Thursday. Peregrine Pharmaceuticals (NASDAQ PHM) also experienced no change on below-average volume.

On the upside, NuPathe Inc (NASDAQ ATH) was the biggest gainer among biotech companies after its Zecuity was approved by the FDA for the acute treatment of Migraine.

Inovio Pharmaceuticals, Inc. (NYSEAMEX:INO) rose 7.42% on Thursday. Same day, Piper Jaffray analysts initiated coverage on the stock with an overweight rating.

Pacific Biosciences of California (NASDAQ ACB) extended three-day winning streak after Maxim Group lifted its price target from $3.00 to $4.00 on the stock.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) continued to trade near highs yesterday, ending the day up 2.37%.

Incyte Corporation (NASDAQ:INCY) rose 1.6% after analysts at Zacks reiterated their neutral rating.

Biogen Idec Inc. (NASDAQ:BIIB) was up a day after the company and Elan (NYSE:ELN) stated that that they have filed for regulatory approval to increase the use of multiple sclerosis drug Tysabri with the FDA and the European Medicines Agency.

More among biotech gainers were Illumina, Inc. (NASDAQ:ILMN), Zalicus Inc (NASDAQ:ZLCS), Cell Therapeutics Inc (NASDAQ:CTIC) and Gilead Sciences, Inc. (NASDAQ:GILD)

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 361

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 155

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 61

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 251

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 48

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 809

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 208

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 138

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 298

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Batteries Plus Celebrates 31 Years on Franchise 500 List

Updated Category News Views 190

Batteries Plus Secures Spot on Franchise 500 List The world's leading battery retailer, Batteries Plus, has made headlines again by being recognized as one of the top 500 franchises by Entrepreneur Magazine. This remarkable achievement marks the 31st consecutive year that the brand has secured a place on this coveted list. With this year's ranking showcasing a jump of 20...

Continue Reading
Nvidia and Broadcom Lead the Charge in the AI Revolution

Updated Category News Views 263

The Rise of Nvidia and Broadcom in AI Technology The technology landscape is rapidly evolving, primarily driven by advancements in artificial intelligence (AI). Leaders in this space, Nvidia Corp (NASDAQ: NVDA) and Broadcom Inc (NASDAQ: AVGO), are setting the foundation for the future with their innovative silicon solutions. The focus is shifting towards hardware...

Continue Reading
Highlights from the Fusion Commission's New Appointments

Updated Category News Views 407

Exciting Developments in Fusion Energy Leadership The Special Competitive Studies Project (SCSP) is creating buzz in the fusion energy sector with its recent announcement regarding the final two commissioners, Manu Asthana and Dr. Rachel Slaybaugh. This initiative brings together some of the brightest minds in the field, all focused on advancing nuclear technologies and...

Continue Reading
Copenhagen Airports A/S Announces Preliminary Tender Offer Results

Updated Category News Views 96

Overview of the Tender Offer Results Copenhagen Airports A/S is pleased to share significant updates regarding the tender offer presented to its shareholders. The notification received from the Kingdom of Denmark highlights the preliminary outcomes, giving stakeholders vital insights into the ongoing financial strategies of the company. Key Information for Shareholders...

Continue Reading
AMC Networks Inc Faces Legal Scrutiny Amid Financial Losses

Updated Category News Views 195

AMC Networks Inc Faces Legal Scrutiny Amid Financial Challenges AMC Networks Inc, a well-known entity in the entertainment industry, is experiencing turbulent times as allegations of securities fraud surface. Investors are urged to take notice of these developments that might affect their interests. Investigation by Pomerantz LLP Pomerantz LLP, a prominent law firm...

Continue Reading